Skip to main content
SpringerLink
Log in

Developmental Pharmacology: Impact on Pharmacokinetics and Pharmacodynamics of Drugs

  • Chapter
  • First Online:
Fundamentals of Pediatric Drug Dosing

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 149.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 149.00
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Kearns GL, Abdel-Rahman SM, Alander SW, Blowey DL, Leeder JS et al (2003) Developmental pharmacology: drug disposition, action, and therapy in infants and children. N Engl J Med 349:1157–1167

    Article  CAS  PubMed  Google Scholar 

  2. Alcorn J, McNamara PJ (2002) Ontogeny of hepatic and renal systemic clearance pathways in infants: part I. Clin Pharmacokinet 41:959–998

    Article  CAS  PubMed  Google Scholar 

  3. Alcorn J, McNamara PJ (2002) Ontogeny of hepatic and renal systemic clearance pathways in infants: part II. Clin Pharmacokinet 41:1077–1094

    Article  CAS  PubMed  Google Scholar 

  4. Gibaldi M (1984) Gastrointestinal absorption: physicochemical considerations. In: Biopharmaceutics and clinical pharmacokinetics, 3rd edn. Lea and Febiger, Philadelphia, pp 44–63

    Google Scholar 

  5. Huang NN, High RH (1953) Comparison of serum levels following the administration of oral and parenteral preparations of penicillin to infants and children of various age groups. J Pediatr 42:657–668

    Article  CAS  PubMed  Google Scholar 

  6. Linday L, Dobkin JF, Wang TC, Butler VP Jr, Saha JR et al (1987) Digoxin inactivation by the gut flora in infancy and childhood. Pediatrics 79:544–548

    CAS  PubMed  Google Scholar 

  7. Loebstein R, Koren G (1998) Clinical pharmacology and therapeutic drug monitoring in neonates and children. Pediatr Rev 19:423–428

    CAS  PubMed  Google Scholar 

  8. McClean P, Weaver LT (1993) Ontogeny of human pancreatic exocrine function. Arch Dis Child 68:62–65

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Alcorn J, McNamara PJ (2003) Pharmacokinetics in the newborn. Adv Drug Del Rev 55:667–686

    Article  CAS  Google Scholar 

  10. Johnson TN, Tanner MS, Christopher J, Taylor CJ, Tucker GT (2001) Enterocytic CYP3A4 in a pediatric population: developmental changes and the effect of coeliac disease and cystic fibrosis. Br J Clin Pharmacol 51:451–460

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Stahlberg MR, Hietanen E, Maki M (1988) Mucosal biotransformation rates in the small intestine of children. Gut 29:1058–1063

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Gibbs JP, Liacouras CA, Baldassano RN, Slattery JT (1999) Up-regulation of glutathione S-transferase activity in enterocytes of young children. Drug Metab Dispos 27:1466–1469

    CAS  PubMed  Google Scholar 

  13. Yaffe SJ, Juchau MR (1974) Perinatal pharmacology. Annu Rev Pharmacol 14:219–238

    Article  CAS  Google Scholar 

  14. Fluhr JW, Pfisterer S, Gloor M (2000) Direct comparison of skin physiology in children and adults with bioengineering methods. Pediatr Dermatol 17:436–439

    Article  CAS  PubMed  Google Scholar 

  15. Okah FA, Wickett RR, Pickens WL, Hoath SB (1995) Surface electrical capacitance as a noninvasive bedside measure of epidermal barrier maturation in the newborn infant. Pediatrics 96:688–692

    CAS  PubMed  Google Scholar 

  16. Rutter N (1987) Percutaneous drug absorption in the newborn: hazards and uses. Clin Perinatol 14:911–930

    CAS  PubMed  Google Scholar 

  17. Amato M, Huppi P, Isenschmid M, Schneider H (1992) Developmental aspects of percutaneous caffeine absorption in premature infants. Am J Perinatol 9:431–434

    Article  CAS  PubMed  Google Scholar 

  18. West DP, Worobec S, Solomon LM (1981) Pharmacology and toxicology of infant skin. J Invest Dermatol 76:147–150

    Article  CAS  PubMed  Google Scholar 

  19. Greenblatt DJ, Koch-Weser J (1976) Intramuscular injection of drugs. N Engl J Med 295:542–546

    Article  CAS  PubMed  Google Scholar 

  20. Kafetzis DA, Sinaniotis CA, Papadatos CJ, Kosmidis J (1979) Pharmacokinetics of amikacin in infants and pre-school children. Acta Paediatr Scand 68:419–422

    Article  CAS  PubMed  Google Scholar 

  21. Sheng KT, Huang NN, Promadhattavedi V (1964) Serum concentrations of cephalothin in infants and children and placental transmission of the antibiotic. Antimicrob Agents Chemother 10:200–206

    CAS  PubMed  Google Scholar 

  22. Windorfer A, Kuenzer W, Urbanek R (1974) The influence of age on the activity of acetylsalicylic acid-esterase and protein-salicylate binding. Eur J Clin Pharmacol 7:227–231

    Article  CAS  PubMed  Google Scholar 

  23. Tetelbaum M, Finkelstein Y, Nava-Ocampo AA, Koren G (2005) Back to basics: understanding drugs in children: pharmacokinetic maturation. Pediatr Rev 26:321–328

    Article  PubMed  Google Scholar 

  24. Gibaldi M (1984) Drug disposition-distribution. In: Biopharmaceutics and clinical pharmacokinetics, 3rd edn. Lea and Febiger, Philadelphia, pp 168–180

    Google Scholar 

  25. Leeder JS, Adcock K, Gaedlig K. Acquisition of CYP2D6 and CYP3A4 activities in the first year of life. Clin Pharmacol Ther. 2000;67:169(Abstract).

    Google Scholar 

  26. Ehrnebo M, Agurell S, Jalling B, Boreus LO (1971) Age differences in drug binding by plasma proteins: studies on human fetuses, neonates and adults. Eur J Clin Pharmacol 3:189–193

    Article  CAS  PubMed  Google Scholar 

  27. McNammara PJ, Alcorn J (2002) Protein binding predictions in infants. AAPS Pharma Sci 4:1–8

    Google Scholar 

  28. Gorodischer R, Jusko WJ, Yaffe SJ (1976) Tissue and erythrocyte distribution of digoxin in infants. Clin Pharmacol Ther 19:256–263

    Article  CAS  PubMed  Google Scholar 

  29. Kearin M, Kelly JG, O'Malley K (1980) Digoxin “receptors” in neonates: an explanation of less sensitivity to digoxin in adults. Clin Pharmacol Therap 28:346–349

    Article  CAS  Google Scholar 

  30. Benedetti MS, Baltes EL (2003) Drug metabolism and disposition in children. Fund Clin Pharmacol 17:281–299

    Article  Google Scholar 

  31. Niederhauser VP (1997) Prescribing for children: issues in pediatric pharmacology. Nurse Pract 22:16–18

    Article  CAS  PubMed  Google Scholar 

  32. Blanco JG, Harrison PL, Evans WE et al (2000) Human cytochrome P450 maximal activities in pediatric versus adult liver. Drug Metab Disp 28:379–382

    CAS  Google Scholar 

  33. de Wildt SN, Kearns GL, Leeder JS, van den Anker JN (1999) Cytochrome P450 3A: ontogeny and drug disposition. Clin Pharmacokinet 37:485–505

    Article  PubMed  Google Scholar 

  34. Lacroix D, Sonnier M, Moncion A, Cheron G, Cresteil T (1997) Expression of CYP3A in the human liver–evidence that the shift between CYP3A7 and CYP3A4 occurs immediately after birth. Eur J Biochem 247:625–634

    Article  CAS  PubMed  Google Scholar 

  35. Pearce R, Greenway D, Parkinson A (1992) Species differences and interindividual variation in liver microsomal cytochrome P450 2A enzymes: effects on coumarin, dicumarol, and testosterone oxidation. Arch Biochem Biophys 298:211–225

    Article  CAS  PubMed  Google Scholar 

  36. Tateishi T, Nakura H, Asoh M, Watanabe M, Tanaka M et al (1997) A comparison of hepatic cytochrome P450 protein expression between infancy and postinfancy. Life Sci 61:2567–2574

    Article  CAS  PubMed  Google Scholar 

  37. Butler MA, Iwasaki M, Guengerich FP, Kadlubar FF (1989) Human cytochrome P-450PA (P-450IA2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines. Proc Natl Acad Sci U S A 86:7696–7700

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Sonnier M, Cresteil T (1998) Delayed ontogenesis of CYP1A2 in the human liver. Eur J Biochem 251:893–898

    Article  CAS  PubMed  Google Scholar 

  39. Bauer LA, Blouin R (1983) Phenytoin Michaelis-Menten PK in Caucasian paediatric patients. Clin Pharmacokinet 8:545–549

    Article  CAS  PubMed  Google Scholar 

  40. Chiba K, Ishizaki T, Miura H, Minagawa K (1980) Michaelis-Menten pharmacokinetics of diphenylhydantoin and application in the pediatric age patient. J Pediatr 96(3 Pt 1):479–484

    CAS  PubMed  Google Scholar 

  41. Treluyer JM, Gueret G, Cheron G, Sonnier M, Cresteil T (1997) Developmental expression of CYP2C and CYP2C-dependent activities in the human liver: in-vivo/in-vitro correlation and inducibility. Pharmacogenetics 7:441–452

    Article  CAS  PubMed  Google Scholar 

  42. Leeder JS (2001) Pharmacogenetics and pharmacogenomics. Pediatr Clin North Am 48:765–781

    Article  CAS  PubMed  Google Scholar 

  43. Koukouritaki SB, Manro JR, Marsh SA, Stevens JC, Rettie AE, McCarver DG, Hines RN (2004) Developmental expression of human hepatic CYP2C9 and CYP2C19. J Pharmacol Exp Ther 308:965–974

    Article  CAS  PubMed  Google Scholar 

  44. Peng DR, Birgersson C, von Bahr C, Rane A (1984) Polymorphic acetylation of 7-amino-clonazepam in human liver cytosol. Pediatr Pharmacol 4:155–159

    CAS  Google Scholar 

  45. Daly AK, Brockmoller J, Broly F, Eichelbaum M, Evans WE et al (1996) Nomenclature for human CYP2D6 alleles. Pharmacogenetics 6:193–201

    Article  CAS  PubMed  Google Scholar 

  46. Jakoby WB, Ziegler DM (1990) The enzymes of detoxication. J Biol Chem 265:20715–20718

    CAS  PubMed  Google Scholar 

  47. May DG (1994) Genetic differences in drug disposition. J Clin Pharmacol 34:881–897

    Article  CAS  PubMed  Google Scholar 

  48. de Wildt SN, Kearns GL, Leeder JS, van den Anker JN et al (1999) Glucuronidation in humans. Pharmacogenetic and developmental aspects. Clin Pharmacokinet 36:439–452

    Article  PubMed  Google Scholar 

  49. Onishi S, Kawade N, Itoh S, Isobe K, Sugiyama S (1979) Postnatal development of uridine diphosphate glucuronyltransferase activity towards bilirubin and 2-aminophenol in human liver. Biochem J 184:705–707

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Leakey JE, Hume R, Burchell B (1987) Development of multiple activities of UDP-glucuronyltransferase in human liver. Biochem J 243:859–861

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Pacifici GM, Franchi M, Colizzi C, Giuliani L, Rane A (1988) Glutathione S-transferase in humans: development and tissue distribution. Arch Toxicol 6:265–269

    Article  Google Scholar 

  52. Strange RC, Howie AF, Hume R, Matharoo B, Bell J (1989) The development expression of alpha-, mu- and pi-class glutathione S-transferases in human liver. Biochim Biophys Acta 993:186–190

    Article  CAS  PubMed  Google Scholar 

  53. Levy G, Khanna NN, Soda DM, Tsuzuki O, Stern L (1975) Pharmacokinetics of acetaminophen in the human neonate: formation of acetaminophen glucuronide and sulfate in relation to plasma bilirubin concentration and D-glucaric acid excretion. Pediatrics 55:818–825

    CAS  PubMed  Google Scholar 

  54. McRorie TI, Lynn AM, Nespeca MK, Opheim KF, Slattery JT (1992) The maturation of morphine clearance and metabolism. AJDC 146:972–976

    CAS  PubMed  Google Scholar 

  55. Pacifici GM, Bencini C, Rane A (1986) Acetyltransferase in humans: development and tissue distribution. Pharmacology 32:283–291

    Article  CAS  PubMed  Google Scholar 

  56. Pariente-Khayat A, Pons G, Rey E, Richard MO, D’Athis P (1991) Caffeine acetylator phenotyping during maturation in infants. Pediatr Res 29:492–495

    Article  CAS  PubMed  Google Scholar 

  57. Szorady I, Santa A, Veress I (1987) Drug acetylator phenotypes in newborn infants. Biol Res Pregnancy Perinatol 8:23–25

    CAS  PubMed  Google Scholar 

  58. Tayama Y, Miyake K, Sugihara K, Kitamura S, Kobayashi M et al (2007) Developmental changes of aldehyde oxidase activity in young Japanese children. Clin Pharmacol Therap 81:567–572

    Article  CAS  Google Scholar 

  59. Kornhuber J, Konradi C, Mack-Burkhardt F, Riederer P, Heinsen H et al (1989) Ontogenesis of monoamine oxidase-A and -B in the human brain frontal cortex. Brain Res 499:81–86

    Article  CAS  PubMed  Google Scholar 

  60. Riley LA, Waguespack MA, Denney RM (1989) Characterization and quantitation of monoamine oxidases A and B in mitochondria from human placenta. Mol Pharmacol 36:54–60

    CAS  PubMed  Google Scholar 

  61. Kimura A, Mahara R, Inoue T, Nomura Y, Murai T et al (1999) Profile of urinary bile acids in infants and children: developmental pattern of excretion of unsaturated ketonic bile acids and 7beta-hydroxylated bile acids. Pediatr Res 45(4 Pt 1):603–609

    Article  CAS  PubMed  Google Scholar 

  62. Shargel L, Yu ABC (1993) Drug clearance. In: Introduction to pharmacokinetics: applied biopharmaceutics and pharmacokinetics, 3rd edn. Appleton & Lange, Norwalk, pp 265–292

    Google Scholar 

  63. Arant BS Jr (1978) Developmental patterns of renal functional maturation compared in the human neonate. J Pediatr 92:705–712

    Article  CAS  PubMed  Google Scholar 

  64. Brown RD, Campoli-Richards M (1989) Antimicrobial therapy in neonates, infants and children. Clin Pharmacokinet 17:105–115

    Article  PubMed  Google Scholar 

  65. Jacobs RF, Kearns GL, Brown AL, Trang HM, Kluza RB (1984) Renal clearance of imipenem in children. Eur J Microbiol 3:471–474

    Article  CAS  Google Scholar 

  66. Gibaldi M (1984) Drug disposition-elimination. In: Biopharmaceutics and clinical pharmacokinetics, 3rd edn. Lea & Febiger, Philadelphia, pp 181–205

    Google Scholar 

  67. Jones DP, Chesney RW (1992) Development of tubular function. Clin Perinatol 19:33–57

    CAS  PubMed  Google Scholar 

  68. Hua MJ, Kun HY, Jie CS, Yun NZ, De WQ et al (1997) Urinary microalbumin and retinol-binding protein assay for verifing children’s nephron development and maturation. Clin Chim Acta 264:127–132

    Article  CAS  PubMed  Google Scholar 

  69. Work DF, Schwartz GJ (2008) Estimating and measuring glomerular filtration rate in children. Curr Opin Nephrol Hypertens 17:320–325

    Article  PubMed  Google Scholar 

  70. Schwartz GJ, Work DF (2009) Measurement and estimation of GFR in children and adolescents. Clin J Am Soc Nephrol 4:1832–1843

    Article  PubMed  Google Scholar 

  71. Marshall JD, Kearns GL (1999) Developmental pharmacodynamics of cyclosporine. Clin Pharmacol Ther 66:66–75

    Article  CAS  PubMed  Google Scholar 

  72. Schwartz GJ, Muñoz A, Schneider MF, Mak RH, Kaskel F, Warady BA, Furth SL (2009) New equations to estimate GFR in children with CKD. J Am Soc Nephrol 20:629–637

    Article  PubMed  PubMed Central  Google Scholar 

  73. Bacchetta J, Cochat P, Rognant N, Ranchin B, Hadj-Aissa A, Dubourg L (2011) Which creatinine and cystatin C equations can be reliably used in children? Clin J Am Soc Nephrol 6:552–560

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  74. Pottel H, Hoste L, Martens F (2012) A simple height-independent equation for estimating glomerular filtration rate in children. Pediatr Nephrol 27:973–979

    Article  PubMed  Google Scholar 

  75. Pottel H, Vrydags N, Mahieu B, Vandewynckele E, Croes K, Martens F (2008) Establishing age/sex related serum creatinine reference intervals from hospital laboratory data based on different statistical methods. Clin Chim Acta 396:49–55

    Article  CAS  PubMed  Google Scholar 

  76. Thomas C, Thomas L (2009) Renal Failure-Measuring the glomerular filtration rate. Dtsch Arztebl Int 106:849–854

    PubMed  PubMed Central  Google Scholar 

  77. Grubb A, Nyman U, Björk J, Lindström V, Rippe B, Sterner G, Christensson A (2005) Simple cystatin C-based prediction equations for glomerular filtration rate compared with the modification of diet in renal disease prediction equation for adults and the Schwartz and the Counahan-Barratt prediction equations for children. Clin Chem 51:1420–1431

    Article  CAS  PubMed  Google Scholar 

  78. Kauffman RE, Lieh-Lai MW, Uy HG, Aravind MK (1999) Enantiomer-selective pharmacokinetics and metabolism of ketorolac in children. Clin Pharmacol Ther 65:382–388

    Article  CAS  PubMed  Google Scholar 

  79. Lynn AM, Bradford H, Kantor ED, Seng KY, Salinger DH, Chen J, Ellenbogen RG, Vicini P, Anderson GD (2007) Postoperative ketorolac tromethamine use in infants aged 6–18 months: the effect on morphine usage, safety assessment, and stereo-specific pharmacokinetics. Anesth Analg 104:1040–1051

    Article  CAS  PubMed  Google Scholar 

  80. Bressolle F, Rochette A, Khier S, Dadure C, Ouaki J, Capdevila X (2009) Population pharmacokinetics of the two enantiomers of tramadol and O-demethyl tramadol after surgery in children. Br J Anaesth 102:390–399

    Article  CAS  PubMed  Google Scholar 

  81. Takahashi H, Ishikawa S, Nomoto S, Nishigaki Y, Ando F et al (2000) Developmental changes in pharmacokinetics and pharmacodynamics of warfarin enantiomers in Japanese children. Clin Pharmacol Ther 68:541–555

    Article  CAS  PubMed  Google Scholar 

  82. Dong JQ, Ni L, Scott CS, Retsch-Bogart GZ, Smith PC (2000) Pharmacokinetics of ibuprofen enantiomers in children with cystic fibrosis. J Clin Pharmacol 40:861–868

    Article  CAS  PubMed  Google Scholar 

  83. Stephenson T (2005) How children’s responses to drugs differ from adults. Br J Clin Pharmacol 59:670–673

    Article  PubMed  PubMed Central  Google Scholar 

  84. Padbury JF (1998) Neonatal dopamine pharmacodynamics: lessons from the bedside. J Pediatr 133:719–720

    Article  CAS  PubMed  Google Scholar 

  85. Seri I, Abbasi S, Wood DC, Gerdes JS (1998) Regional hemodynamic effects of dopamine in the sick preterm neonate. J Pediatr 133:728–734

    Article  CAS  PubMed  Google Scholar 

  86. Tran A, Rey E, Pons G, Pariente-Khayat A, d’Athis P et al (2002) Pharmacokinetic-pharmacodynamic study of oral lansoprazole in children. Clin Pharmacol Ther 71:359–367

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Clinical Pharmacology, Food & Drug Administration, Rockville, MD, USA

    Iftekhar Mahmood PhD

Authors
  1. Iftekhar Mahmood PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Iftekhar Mahmood PhD .

Editor information

Editors and Affiliations

  1. Clinical Pharmacology/Biopharmaceutics, Food & Drug Administration, Silver Spring, Maryland, USA

    Iftekhar Mahmood

  2. Clinical Pharmacology, Food & Drug Administration, Pediatric Group, Silver Spring, Maryland, USA

    Gilbert Burckart

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Mahmood, I. (2016). Developmental Pharmacology: Impact on Pharmacokinetics and Pharmacodynamics of Drugs. In: Mahmood, I., Burckart, G. (eds) Fundamentals of Pediatric Drug Dosing. Adis, Cham. https://doi.org/10.1007/978-3-319-43754-5_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-43754-5_3

  • Published:

  • Publisher Name: Adis, Cham

  • Print ISBN: 978-3-319-43752-1

  • Online ISBN: 978-3-319-43754-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation